{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:21:48Z","timestamp":1791264108213,"version":"4.1.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T00:00:00Z","timestamp":1449705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12072-015-9684-3","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T05:14:15Z","timestamp":1449983655000},"page":"415-423","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["Hepatitis C virus as a systemic disease: reaching beyond the liver"],"prefix":"10.1007","volume":"10","author":[{"given":"Kirat","family":"Gill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasmik","family":"Ghazinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Manch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,10]]},"reference":[{"key":"9684_CR1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3760\/cma.j.issn.0366-6999.20132988","volume":"127","author":"Z Cheng","year":"2014","unstructured":"Cheng Z, Zhou B, Shi X, et al. Extrahepatic manifestations of chronic hepatitis C virus infection: 297 cases from a tertiary medical center in Beijing, China. Chin Med J (Engl). 2014;127:1206\u20131210.","journal-title":"Chin Med J (Engl)"},{"key":"9684_CR2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","volume":"42","author":"P Cacoub","year":"1999","unstructured":"Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. multidepartment virus C. Arthritis Rheum. 1999;42:2204\u20132212.","journal-title":"Arthritis Rheum"},{"key":"9684_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11894-006-0064-y","volume":"8","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep. 2006;8:53\u201359.","journal-title":"Curr Gastroenterol Rep"},{"issue":"Suppl 5","key":"9684_CR4","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","volume":"46","author":"P Cacoub","year":"2014","unstructured":"Cacoub P, Gragnani L, Comarmond C, et al. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis. 2014;46(Suppl 5):S165\u2013173.","journal-title":"Dig Liver Dis"},{"key":"9684_CR5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, et al. The cryoglobulinaemias. Lancet. 2012;379:348\u2013360.","journal-title":"Lancet"},{"key":"9684_CR6","doi-asserted-by":"crossref","first-page":"502156","DOI":"10.1155\/2012\/502156","volume":"2012","author":"G Lauletta","year":"2012","unstructured":"Lauletta G, Russi S, Conteduca V, et al. Hepatitis C virus infection and mixed cryoglobulinemia. Clin Dev Immunol. 2012;2012:502156.","journal-title":"Clin Dev Immunol"},{"key":"9684_CR7","first-page":"111","volume":"2","author":"FM Lunel","year":"1996","unstructured":"Lunel FM, Musset L. Hepatitis C virus infection and cryoglobulinemia. Viral Hepat Rev. 1996;2:111\u2013124.","journal-title":"Viral Hepat Rev"},{"issue":"4","key":"9684_CR8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep.1840190407","volume":"19","author":"JM Pawlotsky","year":"1994","unstructured":"Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zafrani ES, Duval J, Dhumeaux, D. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology. 1994;19(4):841\u20138. doi: 10.1002\/hep.1840190407 .","journal-title":"Hepatology."},{"key":"9684_CR9","first-page":"191","volume":"9","author":"Z Jadali","year":"2010","unstructured":"Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010;9:191\u2013206.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"9684_CR10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.critrevonc.2008.03.008","volume":"67","author":"U Vitolo","year":"2008","unstructured":"Vitolo U, Ferreri AJ, Montoto S. Lymphoplasmacytic lymphoma-Waldenstrom\u2019s macroglobulinemia. Crit Rev Oncol Hematol. 2008;67:172\u2013185.","journal-title":"Crit Rev Oncol Hematol"},{"key":"9684_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2110-5820-2-31","volume":"2","author":"M Zaidan","year":"2012","unstructured":"Zaidan M, Mariotte E, Galicier L, et al. Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitis. Ann Intensive Care. 2012;2:31.","journal-title":"Ann Intensive Care"},{"key":"9684_CR12","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.3748\/wjg.v20.i24.7544","volume":"20","author":"A Ozkok","year":"2014","unstructured":"Ozkok A, Yildiz A. Hepatitis C virus associated glomerulopathies. World J Gastroenterol. 2014;20:7544\u20137554.","journal-title":"World J Gastroenterol"},{"key":"9684_CR13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03710708","volume":"4","author":"N Perico","year":"2009","unstructured":"Perico N, Cattaneo D, Bikbov B, et al. Hepatitis C infection and chronic renal diseases. Clin J Am Soc Nephrol. 2009;4:207\u2013220.","journal-title":"Clin J Am Soc Nephrol"},{"key":"9684_CR14","first-page":"695","volume":"3","author":"NJ Schamberg","year":"2007","unstructured":"Schamberg NJ, Lake-Bakaar GV. Hepatitis C virus-related mixed cryoglobulinemia: pathogenesis, clinical manifestations, and new therapies. Gastroenterol Hepatol (N Y). 2007;3:695\u2013703.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"9684_CR15","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"DFA Longo","year":"2011","unstructured":"Longo DFA, Kasper DL, Hauser S, Jameson J, Loscalzo J. Harrison\u2019s Principles of Internal Medicine. 18th ed. New York: McGraw-Hill; 2011.","edition":"18"},{"key":"9684_CR16","first-page":"89","volume":"48","author":"S Gandolfo","year":"2002","unstructured":"Gandolfo S, Carrozzo M. Lichen planus and hepatitis C virus infection. Minerva Gastroenterol Dietol. 2002;48:89.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"9684_CR17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1601-0825.2010.01670.x","volume":"16","author":"G Lodi","year":"2010","unstructured":"Lodi G, Pellicano R, Carrozzo M. Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis. 2010;16:601\u2013612.","journal-title":"Oral Dis"},{"key":"9684_CR18","first-page":"326","volume":"6","author":"BE Fortune","year":"2010","unstructured":"Fortune BE, Francis S, Forman LM. Hepatitis C virus therapy-related skin manifestations. Gastroenterol Hepatol (N Y). 2010;6:326\u2013328.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"9684_CR19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004836-199712000-00013","volume":"25","author":"EA Akriviadis","year":"1997","unstructured":"Akriviadis EA, Xanthakis I, Navrozidou C, et al. Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha. J Clin Gastroenterol. 1997;25:612\u2013618.","journal-title":"J Clin Gastroenterol"},{"key":"9684_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.14218\/JCTH.2015.00010","volume":"3","author":"B Dedania","year":"2015","unstructured":"Dedania B, Wu GY. Dermatologic extrahepatic manifestations of hepatitis C. J Clin Transl Hepatol. 2015;3:127\u2013133.","journal-title":"J Clin Transl Hepatol"},{"key":"9684_CR21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1056\/NEJMc1101858","volume":"364","author":"R Kapoor","year":"2011","unstructured":"Kapoor R, Johnson RA. Necrolytic acral erythema. N Engl J Med. 2011;364:1479\u20131480.","journal-title":"N Engl J Med"},{"key":"9684_CR22","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s10620-010-1273-7","volume":"55","author":"JH Tabibian","year":"2010","unstructured":"Tabibian JH, Gerstenblith MR, Tedford RJ, et al. Necrolytic acral erythema as a cutaneous marker of hepatitis C: report of two cases and review. Dig Dis Sci. 2010;55:2735\u20132743.","journal-title":"Dig Dis Sci"},{"key":"9684_CR23","first-page":"740138","volume":"2012","author":"HM Ko","year":"2012","unstructured":"Ko HM, Hernandez-Prera JC, Zhu H, et al. Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol. 2012;2012:740138.","journal-title":"Clin Dev Immunol"},{"key":"9684_CR24","first-page":"1123","volume":"17","author":"A Tsoumani","year":"2013","unstructured":"Tsoumani A, Theopistos V, Katsanos K, et al. Treatment and non-treatment related ocular manifestations in patients with chronic hepatitis B or C. Eur Rev Med Pharmacol Sci. 2013;17:1123\u20131131.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"9684_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2893.2011.01554.x","volume":"19","author":"M Stepanova","year":"2012","unstructured":"Stepanova M, Lam B, Younossi Y, et al. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity. J Viral Hepat. 2012;19:341\u2013345.","journal-title":"J Viral Hepat"},{"issue":"Suppl 2","key":"9684_CR26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s12072-013-9460-1","volume":"7","author":"A Mangia","year":"2013","unstructured":"Mangia A, Ripoli M. Insulin resistance, steatosis and hepatitis C virus. Hepatol Int. 2013;7(Suppl 2):782\u2013789.","journal-title":"Hepatol Int"},{"key":"9684_CR27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/apt.12234","volume":"37","author":"ZM Younossi","year":"2013","unstructured":"Younossi ZM, Stepanova M, Nader F, et al. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther. 2013;37:647\u2013652.","journal-title":"Aliment Pharmacol Ther"},{"key":"9684_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","volume":"38","author":"SH Mehta","year":"2003","unstructured":"Mehta SH, Brancati FL, Strathdee SA, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology. 2003;38:50\u201356.","journal-title":"Hepatology"},{"key":"9684_CR29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","volume":"166","author":"CS Wang","year":"2007","unstructured":"Wang CS, Wang ST, Yao WJ, et al. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol. 2007;166:196\u2013203.","journal-title":"Am J Epidemiol"},{"key":"9684_CR30","author":"CH Chien","year":"2015","unstructured":"Chien CH, Lin CL, Hu CC, et al. Clearance of hepatitis c virus improves insulin resistance during and after peginterferon and ribavirin therapy. J Interferon Cytokine Res 2015. doi: 10.1089\/jir.2014.0200 .","journal-title":"J Interferon Cytokine Res"},{"key":"9684_CR31","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3748\/wjg.15.1537","volume":"15","author":"F Negro","year":"2009","unstructured":"Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol. 2009;15:1537\u20131547.","journal-title":"World J Gastroenterol"},{"key":"9684_CR32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","volume":"49","author":"DL White","year":"2008","unstructured":"White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008;49:831\u2013844.","journal-title":"J Hepatol"},{"key":"9684_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0140-6736(92)91645-O","volume":"339","author":"J Haddad","year":"1992","unstructured":"Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjogren\u2019s syndrome associated with chronic hepatitis C virus liver disease. Lancet. 1992;339:321\u2013323.","journal-title":"Lancet"},{"key":"9684_CR34","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.3748\/wjg.v20.i24.7534","volume":"20","author":"M Carrozzo","year":"2014","unstructured":"Carrozzo M, Scally K. Oral manifestations of hepatitis C virus infection. World J Gastroenterol. 2014;20:7534\u20137543.","journal-title":"World J Gastroenterol"},{"key":"9684_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2009.06.001","volume":"392","author":"H Zur Hausen","year":"2009","unstructured":"Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392:1\u201310.","journal-title":"Virology."},{"key":"9684_CR36","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030\u20133044.","journal-title":"Int J Cancer"},{"key":"9684_CR37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S1677-55382011000200009","volume":"37","author":"A Krystyna","year":"2011","unstructured":"Krystyna A, Safi T, Briggs WM, et al. Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration. Int Braz J Urol. 2011;37:223\u2013229.","journal-title":"Int Braz J Urol"},{"key":"9684_CR38","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1600-0714.1995.tb01199.x","volume":"24","author":"Y Nagao","year":"1995","unstructured":"Nagao Y, Sata M, Tanikawa K, et al. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med. 1995;24:354\u2013360.","journal-title":"J Oral Pathol Med"},{"key":"9684_CR39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF03401317","volume":"13","author":"P Fallahi","year":"2014","unstructured":"Fallahi P, Ferrari SM, Giuggioli D, et al. Thyroid involvement in hepatitis C-associated mixed cryoglobulinemia. Hormones (Athens). 2014;13:16\u201323.","journal-title":"Hormones (Athens)"},{"key":"9684_CR40","doi-asserted-by":"crossref","first-page":"11054","DOI":"10.3748\/wjg.v20.i32.11054","volume":"20","author":"C Visco","year":"2014","unstructured":"Visco C, Finotto S. Hepatitis C virus and diffuse large B-cell lymphoma: pathogenesis, behavior and treatment. World J Gastroenterol. 2014;20:11054\u201311061.","journal-title":"World J Gastroenterol"},{"key":"9684_CR41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/1471-2407-11-495","volume":"11","author":"FH Su","year":"2011","unstructured":"Su FH, Chang SN, Chen PC, et al. Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study. BMC Cancer. 2011;11:495.","journal-title":"BMC Cancer"},{"key":"9684_CR42","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.3748\/wjg.v16.i29.3687","volume":"16","author":"D Larrey","year":"2010","unstructured":"Larrey D, Bozonnat MC, Kain I, et al. Is chronic hepatitis C virus infection a risk factor for breast cancer? World J Gastroenterol. 2010;16:3687\u20133691.","journal-title":"World J Gastroenterol"},{"key":"9684_CR43","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","volume":"14","author":"Y Arase","year":"2008","unstructured":"Arase Y, Suzuki F, Suzuki Y, et al. Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol. 2008;14:5880\u20135886.","journal-title":"World J Gastroenterol"},{"key":"9684_CR44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/thx.51.3.315","volume":"51","author":"R Meliconi","year":"1996","unstructured":"Meliconi R, Andreone P, Fasano L, et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax. 1996;51:315\u2013317.","journal-title":"Thorax"},{"key":"9684_CR45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11938-006-0007-6","volume":"9","author":"MA Rifai","year":"2006","unstructured":"Rifai MA, Indest D, Loftis J, et al. Psychiatric management of the hepatitis C patient. Curr Treat Options Gastroenterol. 2006;9:508\u2013519.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"9684_CR46","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1365-2893.2007.00885.x","volume":"14","author":"AA Butt","year":"2007","unstructured":"Butt AA, Khan UA, McGinnis KA, et al. Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans. J Viral Hepat. 2007;14:890\u2013896.","journal-title":"J Viral Hepat"},{"key":"9684_CR47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-5618.2007.00472.x","volume":"10","author":"AM Matthews","year":"2008","unstructured":"Matthews AM, Huckans MS, Blackwell AD, et al. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord. 2008;10:266\u2013270.","journal-title":"Bipolar Disord"},{"key":"9684_CR48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00003495-200666020-00003","volume":"66","author":"JM Loftis","year":"2006","unstructured":"Loftis JM, Matthews AM, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs. 2006;66:155\u2013174.","journal-title":"Drugs"},{"key":"9684_CR49","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.mcg.0000173860.08478.a6","volume":"39","author":"PJ Rowan","year":"2005","unstructured":"Rowan PJ, Al-Jurdi R, Tavakoli-Tabasi S, et al. Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. J Clin Gastroenterol. 2005;39:731\u2013736.","journal-title":"J Clin Gastroenterol"},{"key":"9684_CR50","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.20014","volume":"39","author":"O Dalgard","year":"2004","unstructured":"Dalgard O, Egeland A, Skaug K, et al. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology. 2004;39:74\u201380.","journal-title":"Hepatology"},{"key":"9684_CR51","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.27422","volume":"61","author":"JA Boscarino","year":"2015","unstructured":"Boscarino JA, Lu M, Moorman AC, et al. Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology. 2015;61:802\u2013811.","journal-title":"Hepatology"},{"key":"9684_CR52","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/ajg.2009.346","volume":"104","author":"AA John-Baptiste","year":"2009","unstructured":"John-Baptiste AA, Tomlinson G, Hsu PC, et al. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Am J Gastroenterol. 2009;104:2439\u20132448.","journal-title":"Am J Gastroenterol"},{"key":"9684_CR53","doi-asserted-by":"crossref","first-page":"e8340","DOI":"10.5812\/hepatmon.8340","volume":"13","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A, Poustchi H, Malekzadeh R. Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature review. Hepat Mon. 2013;13:e8340.","journal-title":"Hepat Mon"},{"key":"9684_CR54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/etm.2014.1709","volume":"8","author":"XR Mao","year":"2014","unstructured":"Mao XR, Zhang LT, Chen H, et al. Possible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patients. Exp Ther Med. 2014;8:133\u2013140.","journal-title":"Exp Ther Med"},{"key":"9684_CR55","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0248-8663(00)88683-X","volume":"20","author":"C Broussolle","year":"1999","unstructured":"Broussolle C, Steineur MP, Bailly F, et al. [Hepatitis C virus infection and thyroid diseases]. Rev Med Interne. 1999;20:766\u2013773.","journal-title":"Rev Med Interne"},{"key":"9684_CR56","doi-asserted-by":"crossref","first-page":"63S","DOI":"10.1007\/BF02087878","volume":"41","author":"SJ Hadziyannis","year":"1996","unstructured":"Hadziyannis SJ. Nonhepatic manifestations and combined diseases in HCV infection. Dig Dis Sci. 1996;41:63S\u201374S.","journal-title":"Dig Dis Sci"},{"key":"9684_CR57","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archinte.158.13.1445","volume":"158","author":"L Fernandez-Soto","year":"1998","unstructured":"Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, et al. Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med. 1998;158:1445\u20131448.","journal-title":"Arch Intern Med"},{"key":"9684_CR58","unstructured":"World Health Organization. The top 10 causes of death. 2014. http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/ . Accessed 20 Sept 2014."},{"key":"9684_CR59","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s10620-014-3222-3","volume":"59","author":"RJ Wong","year":"2014","unstructured":"Wong RJ, Kanwal F, Younossi ZM, et al. Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature. Dig Dis Sci. 2014;59:1586\u20131593.","journal-title":"Dig Dis Sci"},{"key":"9684_CR60","first-page":"e31527","volume":"7","author":"CC Liao","year":"2012","unstructured":"Liao CC, Su TC, Sung FC, et al. Does hepatitis C virus infection increase risk for stroke? A population-based cohort study. PLoS ONE. 2012;7:e31527.","journal-title":"A population-based cohort study. PLoS ONE"},{"key":"9684_CR61","doi-asserted-by":"crossref","first-page":"e81305","DOI":"10.1371\/journal.pone.0081305","volume":"8","author":"H He","year":"2013","unstructured":"He H, Kang R, Zhao Z. Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis. PLoS ONE. 2013;8:e81305.","journal-title":"PLoS ONE"},{"key":"9684_CR62","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3748\/wjg.v20.i13.3410","volume":"20","author":"LE Adinolfi","year":"2014","unstructured":"Adinolfi LE, Zampino R, Restivo L, et al. Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World J Gastroenterol. 2014;20:3410\u20133417.","journal-title":"World J Gastroenterol"},{"key":"9684_CR63","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/STROKEAHA.110.598136","volume":"41","author":"MH Lee","year":"2010","unstructured":"Lee MH, Yang HI, Wang CH, et al. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke. 2010;41:2894\u20132900.","journal-title":"Stroke"},{"key":"9684_CR64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2009.10.005","volume":"47","author":"M Boddi","year":"2010","unstructured":"Boddi M, Abbate R, Chellini B, et al. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol. 2010;47:72\u201375.","journal-title":"J Clin Virol"},{"key":"9684_CR65","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2013.08.003","volume":"231","author":"LE Adinolfi","year":"2013","unstructured":"Adinolfi LE, Restivo L, Guerrera B, et al. Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis. 2013;231:22\u201326.","journal-title":"Atherosclerosis"},{"key":"9684_CR66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","volume":"49","author":"AA Butt","year":"2009","unstructured":"Butt AA, Xiaoqiang W, Budoff M, et al. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis. 2009;49:225\u2013232.","journal-title":"Clin Infect Dis"},{"key":"9684_CR67","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1475-097X.2012.01152.x","volume":"32","author":"T Roed","year":"2012","unstructured":"Roed T, Lebech AM, Kjaer A, et al. Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature. Clin Physiol Funct Imaging. 2012;32:421\u2013430.","journal-title":"Clin Physiol Funct Imaging"},{"key":"9684_CR68","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1253\/circj.CJ-08-0459","volume":"72","author":"O Alyan","year":"2008","unstructured":"Alyan O, Kacmaz F, Ozdemir O, et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J. 2008;72:1960\u20131965.","journal-title":"Circ J"},{"key":"9684_CR69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2014.09.022","volume":"62","author":"YH Hsu","year":"2015","unstructured":"Hsu YH, Muo CH, Liu CY, et al. Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9\u00a0years population-based cohort study. J Hepatol. 2015;62:519\u2013525.","journal-title":"J Hepatol"},{"key":"9684_CR70","first-page":"2314","volume":"7","author":"C Demir","year":"2014","unstructured":"Demir C, Demir M. Effect of hepatitis C virus infection on the right ventricular functions, pulmonary arterypressure and pulmonary vascular resistance. Int J Clin Exp Med. 2014;7:2314\u20132318.","journal-title":"Int J Clin Exp Med"},{"key":"9684_CR71","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1871528113666140908113841","volume":"13","author":"S Mariotto","year":"2014","unstructured":"Mariotto S, Ferrari S, Monaco S. HCV-related central and peripheral nervous system demyelinating disorders. Inflamm Allergy Drug Targets. 2014;13:299\u2013304.","journal-title":"Inflamm Allergy Drug Targets"},{"key":"9684_CR72","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12664-014-0509-4","volume":"33","author":"NA Abdelkader","year":"2014","unstructured":"Abdelkader NA, Zaky DZ, Afifi H, et al. Neuropathies in hepatitis C-related liver cirrhosis. Indian J Gastroenterol. 2014;33:554\u2013559.","journal-title":"Indian J Gastroenterol"},{"key":"9684_CR73","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00415-014-7261-7","volume":"261","author":"A Biasiotta","year":"2014","unstructured":"Biasiotta A, Casato M, La Cesa S, et al. Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia. J Neurol. 2014;261:725\u2013731.","journal-title":"J Neurol"},{"key":"9684_CR74","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1128\/JVI.76.19.10064-10068.2002","volume":"76","author":"T Laskus","year":"2002","unstructured":"Laskus T, Radkowski M, Bednarska A, et al. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002;76:10064\u201310068.","journal-title":"J Virol"},{"key":"9684_CR75","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/JVI.76.2.600-608.2002","volume":"76","author":"M Radkowski","year":"2002","unstructured":"Radkowski M, Wilkinson J, Nowicki M, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2002;76:600\u2013608.","journal-title":"J Virol"},{"key":"9684_CR76","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1128\/JVI.78.10.5170-5183.2004","volume":"78","author":"DM Forton","year":"2004","unstructured":"Forton DM, Karayiannis P, Mahmud N, et al. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol. 2004;78:5170\u20135183.","journal-title":"J Virol"},{"key":"9684_CR77","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","volume":"142","author":"NF Fletcher","year":"2012","unstructured":"Fletcher NF, Wilson GK, Murray J, et al. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology. 2012;142:634\u2013643.","journal-title":"Gastroenterology"},{"key":"9684_CR78","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/JVI.01890-08","volume":"83","author":"J Wilkinson","year":"2009","unstructured":"Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol. 2009;83:1312\u20131319.","journal-title":"J Virol"},{"key":"9684_CR79","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2002.30688","volume":"35","author":"DM Forton","year":"2002","unstructured":"Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology. 2002;35:433\u2013439.","journal-title":"Hepatology"},{"key":"9684_CR80","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/ene.12317","volume":"21","author":"WC Chiu","year":"2014","unstructured":"Chiu WC, Tsan YT, Tsai SL, et al. Hepatitis C viral infection and the risk of dementia. Eur J Neurol. 2014;21:1068.","journal-title":"Eur J Neurol"},{"key":"9684_CR81","doi-asserted-by":"crossref","unstructured":"Abdel Rahman TT, Abou Hashem RM, Abdel Guaad MA, et al. Executive functions in chronic hepatitis C virus-infected elderly patients. Geriatr Gerontol Int 2014 [Epub ahead of print].","DOI":"10.12816\/0004512"},{"key":"9684_CR82","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/13854046.2012.758315","volume":"27","author":"TM Umaki","year":"2013","unstructured":"Umaki TM, Denney RL. Neurocognitive deficits associated with the hepatitis C virus among incarcerated men. Clin Neuropsychol. 2013;27:426\u2013436.","journal-title":"Clin Neuropsychol"},{"key":"9684_CR83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S1355617708090085","volume":"15","author":"M Huckans","year":"2009","unstructured":"Huckans M, Seelye A, Parcel T, et al. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc. 2009;15:69\u201382.","journal-title":"J Int Neuropsychol Soc"},{"key":"9684_CR84","first-page":"910519","volume":"2013","author":"D Isaacs","year":"2013","unstructured":"Isaacs D, Abdelaziz N, Keller M, et al. Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C. Hepat Res Treat. 2013;2013:910519.","journal-title":"Hepat Res Treat"},{"key":"9684_CR85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11938-006-0006-7","volume":"9","author":"Z Kayali","year":"2006","unstructured":"Kayali Z, Labrecque DR, Schmidt WN. Treatment of hepatitis C cryoglobulinemia: mission and challenges. Curr Treat Options Gastroenterol. 2006;9:497\u2013507.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"9684_CR86","author":"L Gerber","year":"2015","unstructured":"Gerber L, Estep M, Stepanova M, et al. Effects of viral eradication with ledipasvir and sofosbuvir, with or without ribavirin, on measures of fatigue in patients with chronic hepatitis c virus infection. Clin Gastroenterol Hepatol. 2015. doi: 10.1016\/j.cgh.2015.07.035 .","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9684_CR87","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jhep.2015.03.014","volume":"63","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Stepanova M, Afdhal N, et al. Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir. J Hepatol. 2015;63:337\u2013345.","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-015-9684-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-015-9684-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T01:03:25Z","timestamp":1718240605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-015-9684-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,10]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["9684"],"URL":"https:\/\/doi.org\/10.1007\/s12072-015-9684-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,10]]}}}